Treatments of Sexual Dysfunction in Opioid Substitution Therapy Patients: A Systematic Review and Meta-Analysis

Fitri Fareez Ramli1, Muhammad Hasif Azizi2, Syed Alhafiz Syed Hashim1

  • 1Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000 Cheras, Kuala Lumpur, Malaysia.

Insights

Treatments like bupropion, trazodone, Rosa Damascena, and ginseng show promise for improving sexual dysfunction in patients undergoing opioid substitution therapy (OST). Adverse effects were minimal, suggesting a safe therapeutic option for this population.

Area of Science:

  • Pharmacology
  • Sexual Health
  • Addiction Medicine

Background:

  • Sexual dysfunction is prevalent among individuals receiving opioid substitution therapy (OST).
  • Addressing sexual dysfunction is crucial for improving the overall well-being and treatment adherence in the OST population.

Purpose of the Study:

  • To evaluate the efficacy and safety of various treatments for sexual dysfunction in patients undergoing OST.
  • To synthesize evidence from interventional studies on pharmacological and herbal interventions.

Main Methods:

  • Systematic literature search of Medline, PubMed, and Scopus for interventional studies.
  • Inclusion of five randomized-controlled trials and two quasi-experimental studies.
  • Risk-of-bias assessment using RoB 2 by three independent authors.
  • Meta-analysis conducted for bupropion's effect on male sexual function.

Main Results:

  • Seven studies involving 473 patients were identified, examining bupropion, trazodone, Rosa Damascena, and ginseng.
  • Bupropion, trazodone, Rosa Damascena, and ginseng demonstrated significant improvements in various sexual functioning domains for both genders.
  • Meta-analysis confirmed bupropion significantly enhanced male sexual function (SMD = 0.53, P < 0.01).
  • All treatments exhibited minor adverse effects with no significant differences compared to placebo in RCTs.

Conclusions:

  • Bupropion, trazodone, Rosa Damascena, and ginseng are promising therapeutic options for sexual dysfunction in the OST population.
  • These agents appear safe with minimal adverse effects.
  • Further research with larger sample sizes is warranted to confirm these findings and guide clinical practice.

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
613
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.1K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
550
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
2.9K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
431
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
538